Resources Management Corp’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.6M | Buy |
85,694
+252
| +0.3% | +$54.2K | 2.72% | 6 |
|
|
2026
Q1 | $18.6M | Buy |
85,442
+1,036
| +1% | +$230K | 2.47% | 10 |
|
|
2025
Q4 | $19.3M | Sell |
84,406
-259
| -0.3% | -$59K | 2.5% | 8 |
|
|
2025
Q3 | $19.6M | Sell |
84,665
-746
| -0.9% | -$152K | 2.53% | 8 |
|
|
2025
Q2 | $15.9M | Buy |
85,411
+77
| +0.1% | +$14.3K | 2.15% | 8 |
|
|
2025
Q1 | $17.9M | Buy |
85,334
+158
| +0.2% | +$30.7K | 2.51% | 6 |
|
|
2024
Q4 | $15.1M | Buy |
85,176
+4,366
| +5% | +$803K | 2.07% | 11 |
|
|
2024
Q3 | $16M | Sell |
80,810
-545
| -0.7% | -$102K | 2.15% | 9 |
|
|
2024
Q2 | $14M | Buy |
81,355
+383
| +0.5% | +$63.4K | 2.03% | 10 |
|
|
2024
Q1 | $14.7M | Sell |
80,972
-6,674
| -8% | -$1.15M | 2.15% | 9 |
|
|
2023
Q4 | $13.6M | Buy |
87,646
+70
| +0.1% | +$10.2K | 2.02% | 10 |
|
|
2023
Q3 | $13.1M | Buy |
87,576
+19
| +0% | +$2.79K | 2.13% | 10 |
|
|
2023
Q2 | $11.8M | Sell |
87,557
-147,032
| -63% | -$21.6M | 1.84% | 13 |
|
|
2023
Q1 | $38.7M | Buy |
234,589
+146,145
| +165% | +$22.3M | 6.22% | 1 |
|
|
2022
Q4 | $14.3M | Sell |
88,444
-587
| -0.7% | -$90K | 2.26% | 10 |
|
|
2022
Q3 | $11.9M | Buy |
89,031
+625
| +0.7% | +$89.7K | 2.06% | 12 |
|
|
2022
Q2 | $13.5M | Buy |
88,406
+79
| +0.1% | +$12.1K | 2.19% | 9 |
|
|
2022
Q1 | $14.3M | Sell |
88,327
-3,060
| -3% | -$444K | 2% | 11 |
|
|
2021
Q4 | $12.4M | Buy |
91,387
+1,335
| +1% | +$158K | 1.61% | 16 |
|
|
2021
Q3 | $9.71M | Buy |
90,052
+80
| +0.1% | +$9.14K | 1.4% | 17 |
|
|
2021
Q2 | $10.1M | Sell |
89,972
-943
| -1% | -$106K | 1.42% | 17 |
|
|
2021
Q1 | $9.84M | Buy |
90,915
+65
| +0.1% | +$6.95K | 1.49% | 17 |
|
|
2020
Q4 | $9.73M | Sell |
90,850
-522
| -0.6% | -$50.2K | 1.57% | 16 |
|
|
2020
Q3 | $8M | Buy |
91,372
+937
| +1% | +$88.2K | 1.44% | 18 |
|
|
2020
Q2 | $8.88M | Buy |
90,435
+1,051
| +1% | +$92.5K | 1.7% | 15 |
|
|
2020
Q1 | $6.81M | Sell |
89,384
-4,095
| -4% | -$349K | 1.52% | 17 |
|
|
2019
Q4 | $8.28M | Buy |
93,479
+2,915
| +3% | +$242K | 1.43% | 23 |
|
|
2019
Q3 | $6.86M | Buy |
+90,564
| New | +$6.21M | 1.27% | 25 |
|
|
2018
Q4 | $7.49M | Sell |
82,006
-1,230
| -1% | -$108K | 1.67% | 18 |
|
|
2018
Q3 | $7.87M | Buy |
+83,236
| New | +$7.89M | 1.44% | 21 |
|
Other funds holding ABBV
Resources Management Corp's ABBV Position: Q2 2026 in Review
Resources Management Corp increased its AbbVie (ABBV) stake by 0.29% in Q2 2026, buying an estimated $54.2K and bringing the position to 85,694 shares worth $21.6M. The position accounts for 2.72% of the portfolio, ranked #6.
Resources Management Corp first reported a position in ABBV in Q3 2018 and has held it in 30 quarters since. The position peaked at $38.7M in Q1 2023. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Resources Management Corp held 85,694 shares of AbbVie worth $21.6M as of Q2 2026.
- Resources Management Corp bought 252 AbbVie shares in Q2 2026, an estimated $54.2K.
- AbbVie made up 2.72% of Resources Management Corp's portfolio in Q2 2026, its #6 holding.
- Resources Management Corp first reported a position in AbbVie in Q3 2018 and has held it in 30 quarters since.
- Resources Management Corp's AbbVie position peaked at $38.7M in Q1 2023.
- 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Resources Management Corp's 13F filing for Q2 2026, filed 14 Aug 2026.